Bernard Davitian to Exit Board of Lexeo Therapeutics

Lexeo Therapeutics, Inc. (LXEO) has issued an update.

Bernard Davitian has informed Lexeo Therapeutics, Inc. that he will not seek re-election at the upcoming annual stockholders’ meeting. This decision is not fueled by any disputes or disagreements over the company’s operational, policy, or practice matters.

See more data about LXEO stock on TipRanks’ Stock Analysis page.